Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?

@article{Onalan2005PredictiveVO,
  title={Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?},
  author={G{\"o}ğşen Onalan and Umit Goktolga and Temel S Ceyhan and Tayfun Bağiş and Reside Onalan and Recai Pabuçcu},
  journal={European journal of obstetrics, gynecology, and reproductive biology},
  year={2005},
  volume={123 2},
  pages={204-11}
}
OBJECTIVE The aim of the present study is to evaluate sub-groups of PCOS patients who will benefit from metformin therapy and to find out any predictors of ovulation in PCOS sub-groups. METHOD In the current prospective-randomized, placebo-controlled, double-blind study, PCOS patients (n = 116) were divided into six main groups according to glucose to insulin ratio (G-I ratio mg/10(-4) U) and body mass index (BMI kg/m2) as: Group 1: normoinsulinemic (G-I ratio > or = 4.5 mg/10(-4) U), lean… CONTINUE READING

From This Paper

Topics from this paper.
16 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…